22-1-1 antigen

Subscribe to Selected New Research on 22-1-1 antigen

4 relevant articles (0 outcomes, 1 trials/studies) found for this Bio-Agent

Description: expressed in cancer cells derived mainly from the uterus and ovary; distinct from the known tumor-associated antigens such as YH 206, GA 733, CA 125, and sialyl Le(x) molecules; MW 78 kDa

Also Known As:

antigen 22-1-1

Bio-Agent Context: Research Results

Biological Factors: 868

Antigens: 93142

Neoplasm Antigens: 1499

22-1-1 antigen: 4

Related Diseases

1.	Neoplasms (Cancer) 05/01/1999 - "This study shows that the 22-1-1 antigen was expressed in cancer cells derived from the uterus, cervix and the ovary and may be a potential tumour marker in the management of gynaecological cancer patients." 05/01/1999 - "A preliminary study of the immunohistochemical detection of a novel tumour marker, 22-1-1 antigen, in gynaecological cancer specimens." 06/01/1998 - "Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias." 06/01/1999 - "Oncol., 6: 1099-1104, 1995) a novel monoclonal antibody, 22-1-1, generated from adenocarcinoma of the uterine cervix, and 22-1-1 antigen (Ag) was expressed in cancer cells derived mainly from the uterus and ovary" 06/01/1999 - "The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix." Get all the results and reference details, order at left...
2.	Adenocarcinoma 05/01/1999 - "A novel tumour associated antigen, 22-1-1, has been recently described in association with a cervical adenocarcinoma cell line" 06/01/1999 - "Oncol., 6: 1099-1104, 1995) a novel monoclonal antibody, 22-1-1, generated from adenocarcinoma of the uterine cervix, and 22-1-1 antigen (Ag) was expressed in cancer cells derived mainly from the uterus and ovary" 06/01/1999 - "The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix." Get all the results and reference details, order at left...
3.	Mucinous Cystadenocarcinoma 05/01/1999 - "This revealed positive staining for the 22-1-1 antigen in 5 out of 6 cases of cervical cancer, 3 out of 5 cases of endometrial cancers, and all 4 cases of ovarian mucinous cystadenocarcinomas" Get all the results and reference details, order at left...
4.	Endometrial Neoplasms (Endometrial Cancer) 05/01/1999 - "This revealed positive staining for the 22-1-1 antigen in 5 out of 6 cases of cervical cancer, 3 out of 5 cases of endometrial cancers, and all 4 cases of ovarian mucinous cystadenocarcinomas" Get all the results and reference details, order at left...
4 Diseases and 4 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Polysaccharides
1 Drugs and Important Bio-Agents and 1 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>